Review Article
Mycobacterium tuberculosis Next-Generation Whole Genome Sequencing: Opportunities and Challenges
Table 2
Summary of methods developed for DNA extraction directly from sputum samples for M. tuberculosis next-generation whole genome sequencing.
| Reference | Sample | Sample preparation for sequencing | Sequencing Platform | Whole genome sequencing success rate () | Coverage; Average Depth of coverage |
| Doyle et al., 2018 [24] | Sputum | SureSelectXT target enrichment system (Agilent technologies) | Illumina MiSeq or NextSeq sequencer | 74.4% | >85%; 25X to 300X |
| Votinseva et al., 2017 [25] | Smear positive sputum | Saline wash, MolYsis Basic5 kit (Molzym, Germany) for depletion of human cells/DNA, Ethanol precipitation method. | Illumina MiSeq sequencer | 62% | >90%; >12X |
| Doughty et al., 2014 [26] | Smear positive sputum | Differential lysis protocol followed by DNA extraction using the NucleoSpin Tissue-Kit (Machery-Nagel, Duren, Germany) | Illumina MiSeq sequencer | 87% | 20% to 99%; 0.002X to 0.7X |
| Brown et al., 2015 [27] | Smear positive sputum | SureSelectXT target enrichment system (Agilent technologies) | Illumina MiSeq sequencer | 83% | 90%; >20X |
|
|